Aurora Cannabis, CTT Pharmaceutical Launch New 'Dissolve Strips' Product Line

Aurora Cannabis Inc. ACB and CTT Pharmaceutical Holdings CTTH announced Tuesday the launch of a new product line of cannabinoid-infused sublingual wafers.

The new line has been launched under the brand name “Dissolve Strips” and is the first of its kind, the company said.

Aurora owns around 9% of CTT, and holds a warrant that can allow it to raise its stake to 42.5%. CTT has also provided Aurora with access to its patent-protected technology for sublingual wafers drug delivery.

Orally dissolvable thin film wafers offer easier drug delivery that doesn’t require water or swallowing, and are also praised for fast absorption, bypassing the liver's first-pass effect.

Pre-IPO Offer: Get A Piece Of A Nearly $5T Global Opportunity By Joining BOXABL As An Early Shareholder At Just $0.80/Share

• Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
• Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
• Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.

Share Price: $0.80

Min. Investment: $1,000

Valuation: $3.5B

Click Here To Invest For Just $0.80/Share ($1000 Min)

Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.

"Aurora's Dissolve Strips™ provide unique advantages over other ingestible products due to their ease of administration, discrete nature and accurate dosage, that provides more rapid bioavailability of cannabinoids via sublingual use," Terry Booth, CEO of Aurora, said in a statement.

"This adds yet another innovative offering to our growing portfolio of high quality, medical products that we offer our patient base, and is testament to our industry leading ability to work with technology partners and regulators to bring new form factors to market rapidly."

CTT's CEO Cam Birge added, "The product launch with Aurora of the Dissolve Strips™ is a major milestone for us that marks the transition of CTT from a technology development phase to a revenue generating phase.”

Aurora's stock closed Monday’s session at $4.11 per share.